ATE110112T1 - Verfahren und systeme zur herstellung von hiv- antigenen. - Google Patents

Verfahren und systeme zur herstellung von hiv- antigenen.

Info

Publication number
ATE110112T1
ATE110112T1 AT89850141T AT89850141T ATE110112T1 AT E110112 T1 ATE110112 T1 AT E110112T1 AT 89850141 T AT89850141 T AT 89850141T AT 89850141 T AT89850141 T AT 89850141T AT E110112 T1 ATE110112 T1 AT E110112T1
Authority
AT
Austria
Prior art keywords
methods
systems
production
hiv antigens
protein
Prior art date
Application number
AT89850141T
Other languages
English (en)
Inventor
Michael F Nunn
Torsten B Helting
Hakan Drevin
Original Assignee
Ferropas Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferropas Ag filed Critical Ferropas Ag
Application granted granted Critical
Publication of ATE110112T1 publication Critical patent/ATE110112T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT89850141T 1988-05-06 1989-05-02 Verfahren und systeme zur herstellung von hiv- antigenen. ATE110112T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19122988A 1988-05-06 1988-05-06
US20649988A 1988-06-13 1988-06-13
US25801688A 1988-10-14 1988-10-14

Publications (1)

Publication Number Publication Date
ATE110112T1 true ATE110112T1 (de) 1994-09-15

Family

ID=27392872

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89850141T ATE110112T1 (de) 1988-05-06 1989-05-02 Verfahren und systeme zur herstellung von hiv- antigenen.

Country Status (4)

Country Link
EP (1) EP0343132B1 (de)
AT (1) ATE110112T1 (de)
DE (1) DE68917520T2 (de)
ES (1) ES2059823T3 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817318A (en) * 1989-05-03 1998-10-06 Connaught Laboratories Limited Synthetic peptides for an HIV-1 vaccine
ES2140380T5 (es) * 1990-03-21 2005-03-16 Geneart Gmbh Secuencias de adn que codifican polipeptidos gag retroviricos modificados y vacunas que las contienen o agregados de las mismas.
DE69231705T2 (de) * 1992-06-04 2001-10-18 The Research Foundation For Microbial Diseases Of Osaka University, Suita Gag-Env Fusion-Antigen aus HIV

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU600658B2 (en) * 1984-12-24 1990-08-23 Genentech Inc. Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
GR862412B (en) * 1985-09-25 1987-01-23 Oncogen Vaccines and immuinoassays for acquired immune deficiency syndrome
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
IE63455B1 (en) * 1987-09-04 1995-04-19 Int Murex Tech Corp Immunoassay and biological constructs for use therein

Also Published As

Publication number Publication date
EP0343132A3 (en) 1990-09-19
ES2059823T3 (es) 1994-11-16
DE68917520T2 (de) 1995-01-05
EP0343132B1 (de) 1994-08-17
DE68917520D1 (de) 1994-09-22
EP0343132A2 (de) 1989-11-23

Similar Documents

Publication Publication Date Title
ATE232237T1 (de) Herstellung von funktionellen, menschlichen urokinaseproteinen
DK371087D0 (da) Mamalialt interleukin-4
ATE176924T1 (de) Verfahren zur herstellung von menschlicher dnase
HUT46061A (en) Dna sequences encoding hirudin-like protein and process for producing such proteins
ES2068907T3 (es) Secuencias de nucleotidos que codifican una proteina con actividad ureasica.
ATE68826T1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
ATE212059T1 (de) Methoden zur identifizierung heterofunktionaler fusionsproteine
FI90667C (fi) Menetelmä valmistaa uutta ihmisen tyypin I interferoniproteiinia
ATE120494T1 (de) Fibronectinbindungsprotein und dessen herstellung.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
FI896261A7 (fi) Menetelmä proteiinin tai polypeptidin valmistamiseksi, polypeptidiä ko odaava DNA-sekvenssi, DNA-sekvenssin sisältämä mikro-organismi sekä po lypeptidi ja sen käyttö farmaseuttisena valmisteena
EP0546087A4 (de)
DK38889A (da) Onkogen-indkodet polypeptid med vaekstfaktoraktivitet
ATE102994T1 (de) Verfahren zur herstellung von proteinen.
EP0572737A3 (de) Gag-Env Fusion-Antigen aus HIV.
DE68917520D1 (de) Verfahren und Systeme zur Herstellung von HIV-Antigenen.
SE8403929D0 (sv) Recombinant dna molecule, transformed microorganisms and process for producing penicillin v amidase
ATE83800T1 (de) Rekombinantes dns-plasmid zur herstellung von xanthangummi.
FI934079L (fi) Menetelmä fuusioproteiinin valmistamiseksi

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties